X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7573) 7573
Publication (878) 878
Book Review (251) 251
Newsletter (210) 210
Book Chapter (164) 164
Newspaper Article (158) 158
Book / eBook (105) 105
Magazine Article (57) 57
Conference Proceeding (27) 27
Dissertation (17) 17
Government Document (9) 9
Reference (8) 8
Report (8) 8
Trade Publication Article (5) 5
Transcript (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4393) 4393
index medicus (4198) 4198
vaccines (4113) 4113
animals (3448) 3448
immunology (3325) 3325
female (2097) 2097
vaccination (2080) 2080
immunization (1680) 1680
vaccine (1650) 1650
mice (1522) 1522
antigens (1430) 1430
medicine, research & experimental (1412) 1412
male (1319) 1319
immunogenicity (1206) 1206
proteins (1200) 1200
health aspects (1145) 1145
immune response (962) 962
infectious diseases (958) 958
adult (947) 947
infections (940) 940
influenza (890) 890
infection (874) 874
research (861) 861
viruses (845) 845
medical research (766) 766
safety (745) 745
microbiology (744) 744
allergy and immunology (735) 735
antibodies (733) 733
analysis (728) 728
prevention (728) 728
middle aged (713) 713
immunotherapy (709) 709
immune-responses (702) 702
clinical trials (698) 698
immunity (694) 694
medicine (641) 641
mice, inbred balb c (624) 624
influenza vaccines - immunology (622) 622
immune system (618) 618
dendritic cells (616) 616
pharmacology & pharmacy (608) 608
veterinary sciences (582) 582
biotechnology & applied microbiology (574) 574
cancer (561) 561
influenza vaccines (546) 546
adolescent (542) 542
adjuvants, immunologic - administration & dosage (539) 539
article (534) 534
studies (533) 533
virology (533) 533
research article (529) 529
antibodies, viral - blood (519) 519
influenza, human - prevention & control (519) 519
vaccines, synthetic - immunology (512) 512
vaccines, subunit - immunology (506) 506
efficacy (504) 504
adjuvant (499) 499
t cells (497) 497
aged (490) 490
medicine, experimental (477) 477
children (457) 457
adjuvants (446) 446
immune-response (441) 441
influenza vaccines - adverse effects (439) 439
review (438) 438
influenza vaccines - administration & dosage (436) 436
public health (429) 429
viral vaccines - immunology (423) 423
multidisciplinary sciences (417) 417
disease (415) 415
clinical trials as topic (409) 409
virus diseases (407) 407
lymphocytes (402) 402
child (401) 401
protection (401) 401
vaccination - methods (386) 386
enzyme-linked immunosorbent assay (385) 385
peptides (384) 384
science (375) 375
care and treatment (374) 374
mortality (368) 368
disease models, animal (359) 359
biology (357) 357
cytokines (354) 354
vaccines - immunology (344) 344
infant (342) 342
responses (338) 338
oncology (337) 337
tuberculosis (335) 335
vaccines, attenuated - immunology (334) 334
lymphocytes t (332) 332
young adult (332) 332
child, preschool (326) 326
antigen (321) 321
t-cell responses (321) 321
virus (321) 321
immunoglobulin g (308) 308
protective immunity (308) 308
treatment outcome (308) 308
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (69) 69
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
Online Resources - Online (5) 5
UofT at Mississauga - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Engineering & Comp. Sci. - Stacks (2) 2
Robarts - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Mt Sinai Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8207) 8207
Russian (16) 16
Spanish (14) 14
German (12) 12
Japanese (11) 11
French (10) 10
Chinese (8) 8
Dutch (2) 2
Italian (1) 1
Persian (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2016, Volume 375, Issue 11, pp. 1019 - 1032
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 11/2016, Volume 120, pp. 1 - 14
Vaccines have been the single most significant advancement in public health, preventing morbidity and mortality in millions of people annually. Vaccine... 
Nanoparticles | Vaccine | SAPN | Adjuvant | Rationally designed | GOLD NANOPARTICLES | HEPATITIS-B-VACCINE | ESCHERICHIA-COLI | NANOPARTICLE VACCINES | MONOPHOSPHORYL-LIPID-A | TOLL-LIKE RECEPTOR-5 | T-CELL RESPONSES | IMMUNE-RESPONSES | VIRUS-LIKE PARTICLES | PHARMACOLOGY & PHARMACY | ANTIGEN-CONTAINING LIPOSOMES | Recombinant Proteins - therapeutic use | Veterinary Drugs - adverse effects | History, 21st Century | Nanoparticles - chemistry | Humans | Vaccines, Synthetic - immunology | Antigens - therapeutic use | Vaccines - chemistry | Allergy and Immunology - history | Nanoparticles - therapeutic use | Vaccines, Subunit - adverse effects | Biopharmaceutics - history | Adjuvants, Immunologic - therapeutic use | Communicable Diseases - veterinary | Chemistry, Pharmaceutical - trends | Vaccines, Synthetic - chemistry | History, 20th Century | Recombinant Proteins - chemistry | Veterinary Drugs - immunology | Protein Engineering - trends | Antigens - chemistry | Communicable Disease Control - trends | Biopharmaceutics - methods | Drug Delivery Systems - trends | Protein Engineering - veterinary | Drug Delivery Systems - adverse effects | Veterinary Drugs - chemistry | Veterinary Drugs - therapeutic use | Drug Delivery Systems - veterinary | Nanoparticles - adverse effects | Recombinant Proteins - adverse effects | Vaccines - therapeutic use | Adjuvants, Immunologic - adverse effects | Antigens - adverse effects | Vaccines, Subunit - therapeutic use | Vaccines, Synthetic - adverse effects | Adjuvants, Immunologic - chemistry | Allergy and Immunology - trends | Drug Design | Chemistry, Pharmaceutical - history | Communicable Disease Control - history | Vaccines, Subunit - chemistry | Biopharmaceutics - trends | Vaccines - immunology | Vaccines, Synthetic - therapeutic use | Vaccines, Subunit - immunology | Protein Folding | Vaccines - adverse effects | Animals | Recombinant Proteins - immunology | Communicable Diseases - immunology | Antigens - immunology | History, 19th Century | Vaccines | Rationally Designed
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 34, Issue 3, pp. 313 - 319
Highlights • CMV seronegative girls between 12 and 17 years of age received CMV glycoprotein B (gB) vaccine with MF59 or saline placebo at 0, 1 and 6 months. •... 
Allergy and Immunology | Cytomegalovirus | Vaccine | CMV gB | Adolescent | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNITY | PREVENTION | TRANSPLANT RECIPIENTS | IMMUNOLOGY | ADJUVANT | PLASMA | DNA | DISEASE | CMV INFECTION | Cytomegalovirus Vaccines - adverse effects | Adjuvants, Immunologic - administration & dosage | Vaccines, Subunit - genetics | Humans | DNA, Viral - analysis | Cytomegalovirus Infections - immunology | Vaccines, Synthetic - immunology | Cytomegalovirus Vaccines - administration & dosage | Antibodies, Viral - blood | Drug-Related Side Effects and Adverse Reactions - pathology | Adjuvants, Immunologic - adverse effects | Cytomegalovirus Infections - prevention & control | Vaccines, Synthetic - adverse effects | Blood - virology | Polymerase Chain Reaction | Polysorbates - administration & dosage | Female | Immunization Schedule | Vaccines, Subunit - adverse effects | Child | Cytomegalovirus Vaccines - genetics | Placebos - administration & dosage | Antigens, Viral - analysis | Polysorbates - adverse effects | Viral Envelope Proteins - genetics | Double-Blind Method | Vaccines, Synthetic - genetics | Squalene - administration & dosage | Urine - virology | Vaccines, Subunit - immunology | Squalene - adverse effects | Drug-Related Side Effects and Adverse Reactions - epidemiology | Vaccines, Subunit - administration & dosage | Viral Envelope Proteins - immunology | Vaccines, Synthetic - administration & dosage | DNA, Viral - genetics | Cytomegalovirus Vaccines - immunology | Clinical trials | Medical colleges | Vaccines | Teenage girls | Antigens | Cytomegalovirus infections | Vaccination | Urine | Confidence intervals | Substance abuse treatment | Consent | Hispanic Americans | Population | Infections | adolescent | vaccine | cytomegalovirus
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 8, pp. 843 - 853
Summary Background Efficacy of live oral rotavirus vaccines is reduced in low-income compared with high-income settings. Parenteral non-replicating rotavirus... 
Infectious Disease | STRAINS | INFECTIOUS DISEASES | PROTECTIVE IMMUNITY | EFFICACY | DISEASE | ADULTS | DEVELOPING-COUNTRIES | CHILDREN | RNA-Binding Proteins - genetics | Immunoglobulin G - blood | Vaccines, Subunit - genetics | Humans | Child, Preschool | Infant | Male | Antibodies, Viral - blood | Drug-Related Side Effects and Adverse Reactions - pathology | Rotavirus Vaccines - adverse effects | Female | Vaccines, Subunit - adverse effects | Placebos - administration & dosage | Rotavirus Vaccines - administration & dosage | Viral Nonstructural Proteins - immunology | Double-Blind Method | Rotavirus Vaccines - immunology | RNA-Binding Proteins - immunology | Viral Nonstructural Proteins - genetics | Vaccines, Subunit - immunology | Drug-Related Side Effects and Adverse Reactions - epidemiology | Rotavirus Vaccines - genetics | Vaccines, Subunit - administration & dosage | Immunoglobulin A - blood | South Africa | Clinical trials | Vaccines | Toddlers | Analysis | Vaccination | Low income groups | Disease | Immunoglobulin G | Medical services | Parents | Income | Homology | Viruses | Infants | Immunoglobulin A | Epidemiology | Tropical diseases | Proteins | Randomization | Replicating | Poliomyelitis | Human immunodeficiency virus--HIV | Licensed products | Safety | Malnutrition | Immunoglobulins | Injection | Typhoid | Studies | Charities | Immunogenicity | Cholera | Index Medicus
Journal Article
by Weller, Michael and Butowski, Nicholas and Tran, David D and Recht, Lawrence and Recht, Lawrence D and Lim, Michael and Hirte, Hal and Ashby, Lynn and Mechtler, Laszlo and Goldlust, Samuel and Goldlust, Samuel A and Iwamoto, Fabio and Drappatz, Jan and O'Rourke, James and O'Rourke, Donald M and Wong, Mark and Hamilton, Mark G and Hamilton, Mark and Finocchiaro, Gaetano and Perry, James and Wick, Wolfgang and Green, Jennifer and He, Yi and Turner, Christopher D and Yellin, Michael J and Keler, Tibor and Davis, Thomas A and Stupp, Roger and Sampson, John H and Campian, Jian and Becker, Kevin and Barnett, Gene and Nicholas, Garth and Desjardins, Annick and Benkers, Tara and Wagle, Naveed and Groves, Morris and Kesari, Santosh and Horvath, Zsolt and Merrell, Ryan and Curry, Richard and Schuster, David and Mrugala, Maciej and Jensen, Randy and Trusheim, John and Lesser, Glenn and Belanger, Karl and Sloan, Andrew and Purow, Benjamin and Fink, Karen and Raizer, Jeffrey and Schulder, Michael and Nair, Suresh and Peak, Scott and Brandes, Alba and Mohile, Nimish and Landolfi, Joseph and Olson, Jon and Jennens, Ross and DeSouza, Paul and Robinson, Bridget and Crittenden, Marka and Shih, Kent and Flowers, Alexandra and Ong, Shirley and Connelly, Jennifer and Hadjipanayis, Costas and Giglio, Pierre and Mott, Frank and Mathieu, David and Lessard, Nathalie and Sepulveda, Sanchez Juan and Lövey, József and Wheeler, Helen and Inglis, Po-Ling and Hardie, Claire and Bota, Daniela and Lesniak, Maciej and Portnow, Jana and Frankel, Bruce and Junck, Larry and Thompson, Reid and Berk, Lawrence and McGhie, John and Macdonald, David and Saran, Frank and Soffietti, Riccardo and Blumenthal, Deborah and André de, Sá Barreto Costa Marcos and Nowak, Anna and Singhal, Nimit and Hottinger, Andreas and Schmid, Andrea and Srkalovic, Gordan and Baskin, David and Fadul, Camilo and Nabors, Louis and LaRocca, Renato and Villano, John and Paleologos, Nina and ... and ACT IV Trial Investigators and ACT IV trial investigators
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1373 - 1385
Rindopepimut (also known as CDX-110), a vaccine targeting the deletion mutation EGFRvIII, consists of an EGFRvIII-specific peptide conjugated to keyhole limpet... 
GLIOMAS | ONCOLOGY | RECURSIVE PARTITIONING ANALYSIS | GROWTH-FACTOR | RADIOTHERAPY | CANCER | PEPTIDE | ADJUVANT TEMOZOLOMIDE | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Brain Neoplasms - pathology | ErbB Receptors - genetics | Gene Expression Regulation, Neoplastic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Patient Selection | Dose-Response Relationship, Drug | Young Adult | Glioblastoma - genetics | Time Factors | Dacarbazine - analogs & derivatives | Adult | Female | Vaccines, Subunit - adverse effects | Brain Neoplasms - mortality | Dacarbazine - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cancer Vaccines - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Neoplasms - genetics | Cancer Vaccines - adverse effects | Treatment Outcome | Brain Neoplasms - drug therapy | Disease-Free Survival | Internationality | Vaccines, Subunit - administration & dosage | Glioblastoma - pathology | Survival Analysis | Aged | Temozolomide | Glioblastoma - drug therapy | Glioblastoma - mortality | Antimitotic agents | Clinical trials | Care and treatment | Product development | Antineoplastic agents | Glioblastoma multiforme | Analysis
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 11/2010, Volume 51, Issue 9, pp. 997 - 1004
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 10/2012, Volume 206, Issue 8, pp. 1280 - 1290
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 12/2017, Volume 216, Issue 11, pp. 1352 - 1361
When the adjuvanted HZ subunit vaccine candidate was coadministered with a quadrivalent seasonal influenza vaccine, no interference in the immune responses... 
Coadministration | Herpes zoster | Adjuvant | Subunit vaccine | Influenza | influenza | POPULATION | INFECTIOUS DISEASES | herpes zoster | subunit vaccine | EFFICACY | MICROBIOLOGY | IMMUNOLOGY | coadministration | IMMUNOSENESCENCE | IMMUNIZATION | RATES | adjuvant | ANTIBODY-RESPONSE | Herpes Zoster - prevention & control | Influenza Vaccines - administration & dosage | Adjuvants, Immunologic - administration & dosage | Adjuvants, Immunologic - pharmacology | Adjuvants, Pharmaceutic - pharmacology | Humans | Middle Aged | Vaccines, Inactivated | Herpesvirus 3, Human - immunology | Male | Antibodies, Viral - blood | Herpes Zoster Vaccine - adverse effects | Adjuvants, Immunologic - adverse effects | Vaccination - methods | Immunity, Humoral | Female | Vaccines, Subunit - adverse effects | Influenza, Human - drug therapy | Seasons | Immunogenicity, Vaccine - immunology | Herpes Zoster Vaccine - immunology | Herpes Zoster - immunology | Antibody Formation - immunology | Vaccines, Subunit - immunology | Drug-Related Side Effects and Adverse Reactions - epidemiology | Influenza Vaccines - immunology | Vaccines, Subunit - administration & dosage | Antibodies, Viral - immunology | Aged | Immunity, Cellular | Drug Combinations | Adjuvants, Pharmaceutic - administration & dosage | Immune response | Viral vaccines | Vaccination | Patient outcomes | Dosage and administration | Research | Methods | Major and Brief Reports | Editor's Choice
Journal Article